Abstract |
One of the most challenging problems in clinical psychiatry are inter-individual differences in clinical response to antipsychotic treatment. Several studies were investigating the impact of the polymorphic cytochrome P450 2D6 gene ( CYP 2D6) on the psychopathological and extrapyramidal symptoms, but the results were conflicting. There is a lack of clinical studies of the impact of CYP2D6 polymorphism on therapeutic efficacy, especially in the long-term treatment of schizophrenia. The aim of the presentation was to evaluate the impact of CYP2D6 genotype on psychopathological and extrapyramidal symptoms in a group of Slovenian outpatients with schizophrenia or schizoaffective disorder in stable remission, who were receiving long-term maintenance therapy.
|
Authors | Blanka Kores Plesnicar, Vita Dolzan, Bojan Zalar |
Journal | Psychiatria Danubina
(Psychiatr Danub)
Vol. 20
Issue 3
Pg. 369-71
(Sep 2008)
ISSN: 0353-5053 [Print] Croatia |
PMID | 18827765
(Publication Type: Journal Article)
|
Chemical References |
- Antipsychotic Agents
- Cytochrome P-450 CYP2D6
|
Topics |
- Adult
- Ambulatory Care
- Antipsychotic Agents
(adverse effects, pharmacokinetics, therapeutic use)
- Basal Ganglia Diseases
(chemically induced, prevention & control)
- Causality
- Cytochrome P-450 CYP2D6
(genetics)
- Genetic Predisposition to Disease
- Genotype
- Humans
- Long-Term Care
- Longitudinal Studies
- Pharmacogenetics
- Phenotype
- Polymorphism, Genetic
- Psychiatric Status Rating Scales
- Psychotic Disorders
(drug therapy, genetics, prevention & control)
- Schizophrenia
(drug therapy, genetics, prevention & control)
- Slovenia
- Treatment Outcome
|